Get started

Smallcaps

$SL1 down trend breakSL1 has remained in down trend since the 4.2c high in July but is now showing signs of a return to strength. Mid September volume reached an all time low around the base established at 1.8c, since this low the volume has stepped back in lifting the SP to the first resistance point at around 2.5c where significant volume has remained. The next resistance point in this case becomes the target at 3.5c This target is supported by underlying fundamental changes in the company which has recently transitioned to a miner with targeted first shipment of zinc early in the October quarter. The second catalyst in support of growth is the highlighted tenement acquisition by the end of December this year. My initial target is 3.5c which represents a 52% increase from the last traded price, stops set at 1.8c which is the all time low representing a favorable risk to reward ratio of 2.4
SLong
by Michaeljob
EKSO - Buy and hold for future exoskeleton growthI have been wanting to get long-term invested in the stocks that I think will greatly benefit from future technology trends. I believe that pure robotics are further in the future than most people realize, but wearable robotics are much closer to adoption. With that opinion I want to be positioning myself in the exoskeleton market. There are a number of very small exoskeleton companies but the one that stands out me the most is EKSO. A few things that stand out are that they are not only penetrating the medical market but they are also heavily focused on the industrial market, where as the other exoskeleton companies are primarily focused on the medical market. Ekso has also recently landed a few contracts, one with the VA and another with Ford that will help them generate the revenue they need to become profitable. As with most small growth companies the biggest risk here is that they are not yet profitable and will need to generate cash flow through debt or stock dilution, which makes it very important to not jump in too earlier. Up until now it has been too early to buy and hold but I believe with the Ford and VA contracts they may be a few quarters from turning the corner and becoming profitable. Price is still a little rich at this point but I will be looking to buy a little bit around $2.20 - $2.00 as a long term speculative buy-and-hold.
NASDAQ:EKSOLong
by krugman87
TRD- move up expectedTRD has been in an rising channel for 6 years. The high of Dec 16/Jan 17 touched the top of the channel and resulted in a pull back and consolidation of 18 months. Price has reacted to the channel and formed a rounded bottom/cup. Likely outcomes are to form a 'handle' for the cup, or for price to move straight up, targeting the upper channel boundary. The fundamentals of this company are excellent, particularly the amount of cash they have in comparison to their market cap. A break of the lower channel boundary would be very bearish.
TLong
by chrisatom
Small Pharma Big Backers and Partners - LONG SNG (Synairgen)Prudent Drug Discovery Company Low market cap ( appox £13m at time of writing ). Issues shares very rarely ( last placing nearly four years ago ). Has material interest in its work from larger partners ( Pharmaxis ). Sold interest in LOXL2 programme for £5m to Pharmaxis in December. Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains interest across all fibrotic indications at circa 17% of all partnering proceeds. Potential of drug appears across multiple uses now ( not just lung-related ) and indications from Pharmaxis looking very good. Recent interviews from Pharmaxis management suggest a good chance of a deal with major pharma in H2. Low free float in the stock ( 60% in hands of major shareholders ). Major funds holding ( Woodford Investment Management and Lansdowne Partners ). High profile investors holding stakes ( Richard Griffiths and Leonard Licht ). These high profile investors have been raising, rather than reducing their stakes in the company, periodically. For a risky smallcap biotech stock it appears well placed to survive and thrive, regardless of the short term success of a sale/licencing deal of LOXL2 by Pharmaxis, making it considerably less risky than most biotech stocks in the long term. However, the indications and noises being made about LOXL2 by Pharmaxis are looking as positive as you could hope for, and backed up by them putting their money where their mouth is in the first place and increasing their stake for cash.
LSE:SNGLong
by richthenewbie
3
MITH/KRW Big upside potential.Looks like Mithril is moving back into bullish mode breaking the mid term resistance and setting higher highs and lower lows in the short term. Drew a coupe line to illustrate what I believe is called a rising wedge. I'm new to this so any help is appreciated. I entered Mithril back when it listed on Bithumb around April 16th, price in USD was $0.67. Rode the bull trend up and sold after the first correction down to the $1 area and after the subsequent relief push back up. All in all made about 80% return on the trade. After price created it's new bottom around $0.50 and getting a pretty strong rejection decided it was a good time to get back in. Entering into the trade today at around $0.59. As far as psychologically influences, the company is strong and is currently accepted in a brick and mortar chain in South Korea, they have a live app called "Lit" which is basically a S Korean Snapchat, I use it daily because that's how new coins are mined. Their way of mining is through a process they coined as "Social Mining". Basically the more you post and the more likes you get the more mithril you get. I believe this mechanic is pretty ingenious because the more people use, it the more they make, and the more people that know about it. Add to the fact that anyone can use it to buy real tangible things already, albeit in a limited capacity. But considering it just hit exchanges in March, id say the growth potential here is pretty significant. And I imagine this next wave will be one for the books. Any criticism is appreciated, thanks.
MLong
by Silvertoe
3
[IWM] Small Caps Leading In Potentially Huge Breakout!Same pattern here that I covered in MSFT, CSCO, and ADBE. All are still consolidating at the breakout level, except for ADBE and IWM. IWM is soaring higher today after finishing a short consolidation period at the breakout level of around $160. I put some Fibonacci lines to show how it bounced strongly off the top of wave 1 around $158.15. Since that low on this morning of 5/16, it's rocketed up past $160 and is hovering around $161 !! Bullish sign for the S&P 500 as well as Nasdaq 100. IWM has shown enough strength through this 4-5 month correction to lead in any major moves and as long as it it can maintain above $160 for a good amount of time, the other indices, as well as the other Triangle Breakout Pattern setups i've charted in Tech stocks, should be gearing up for more upside.
AMEX:IWMLong
by NYFinancials
$LMFA OThe Technicals - A clear divergence of the OBV and Price Action , which preludes growing buyer volume and long position sentiment. Earlier last week, $LMFA hit all time-lows with its bottom at 5 cents above the half dollar. Although we have a considerable amount of selling to break past, I would anticipate the larger corrective retest to occur at the 1.414/1.618 extension, throw some impulse/corrective waves on that bad boy and leg it up. The Fundamentals - Domestic based capital financing/lending company serving the nonprofit sector - overall a safer alternative to other loan portfolios, especially amid the turbulence of global trade and the increasing value of real estate and real-estate development. Recently secured a partnership which appears to have expedited what was already anticipated last week in terms of Price Action . Have not yet read up on these developments (tend to not pay attention to news) but from what I hear, seems to have stirred up investor interest.
NASDAQ:LMFALong
by GregoryMichelson
$BYOC Taps .10 Creating Record 7 Year Highs On Its Way to $1.50+Beyond Commerce a Nevada Corporation boasted tapping the dime mark today igniting the much anticipated record 7 year highs. The company has boasted significant progress since September of last year when it was taken over back by its founder after a lengthy court case with mismanagement of former owners. It is anticipated that gearing up towards further news and updates to come that the stock could variably see a push towards $1.50 - $3.00 mark as the company plans on uplisting to the NASDAQ with the help of Boustead Securities which has listed countless companies on the exchange over the last several decades. The company is anticipated to announce two more acquisitions in the coming months and also plans on major expansion. Updates to come further. This is a current significant growth stock and long term investment in my portfolio.
OTC:BYOCLong
by StockGuild
$GRDO Moves to 60% FIB Retrace and Updates NVSOS with Filing$GRDO paid the fees required to be current with the Nevada SOS. The process to have the revoked status taken off the website should be completed by Friday or latest next week Monday. The stop sign should also be removed by early next month after company goes current which will uplist it to Pink current. The company has been making great strides recently after entering the just now blooming Bitcoin cloud mining niche with its own line of products. Including purchasing mining equipment for the first stages of development. I expect $GRDO to be around .015-.03 by end of Summer time when BTC begins making its way to the 30,000 Mark
GLong
by StockGuild